Antidepressant use, depression, and new-onset diabetes among elderly Medicare beneficiaries

Journal of Diabetes

Volumn 5, Issue 3, 2013, Pages 327-335

  Sambamoorthi, Usha ^a,b   Ma, Yunsheng ^c   Findley, Patricia A ^d   Rust, George ^b  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b MOREHOUSE SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d RUTGERS UNIVERSITY   (United States)

Author keywords

Antidepressants; Depression; Diabetes; Elderly; Epidemiology

Indexed keywords

ANTIDEPRESSANT AGENT; PRESCRIPTION DRUG;

AFRICAN AMERICAN; AGED; ARTICLE; CAUCASIAN; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG USE; FEMALE; FOLLOW UP; HEALTH STATUS; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; OBESITY; PRIORITY JOURNAL; SENESCENCE;

ANTIDEPRESSANTS; DEPRESSION; DIABETES; ELDERLY; EPIDEMIOLOGY;

AGE OF ONSET; AGED; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; DIABETES MELLITUS; EDUCATIONAL STATUS; FEMALE; HUMANS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MEDICARE; MULTIVARIATE ANALYSIS; SOCIAL CLASS; UNITED STATES;

EID: 84881545693     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/1753-0407.12014     Document Type: Article

References (27)

1. Olfson M, Marcus SC. National patterns in antidepressant medication treatment. Arch Gen Psychiatry. 2009; 66: 848-56.
2. Brown LC, Majumdar SR, Johnson JA. Type of antidepressant therapy and risk of type 2 diabetes in people with depression. Diabetes Res Clin Pract. 2008; 79: 61-7.
3. Rubin RR, Ma Y, Marrero DG et al. Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the diabetes prevention program. Diabetes Care. 2008; 31: 420-6.
4. Andersohn F, Schade R, Suissa S, Garbe E. Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus. Am J Psychiatry. 2009; 166: 591-8.
5. Rubin RR, Ma Y, Peyrot M et al. Antidepressant medicine use and risk of developing diabetes during the diabetes prevention program and diabetes prevention program outcomes study. Diabetes Care. 2010; 33: 2549-51.
6. Mitchell PB. Drug interactions of clinical significance with selective serotonin reuptake inhibitors. Drug Saf. 1997; 17: 390-406.
7. Kennedy SH, Lam RW, Cohen NL, Ravindran AV. Clinical guidelines for the treatment of depressive disorders IV. Medications and other biological treatments. Can J Psychiatry. 2001; 46(Suppl. 1): S38-S58.
8. Pan A, Sun Q, Okereke OI et al. Use of antidepressant medication and risk of type 2 diabetes: Results from three cohorts of US adults. Diabetologia. 2012; 55: 63-72.
9. Ma Y, Balasubramanian R, Pagoto SL et al. Elevated depressive symptoms, antidepressant use, and diabetes in a large multiethnic national sample of postmenopausal women. Diabetes Care. 2011; 34: 2390-2.
10. Campayo A, de Jonge P, Roy JF et al. Depressive disorder and incident diabetes mellitus: The effect of characteristics of depression. Am J Psychiatry. 2010; 167: 580-8.
11. Atlantis E, Browning C, Sims J, Kendig H. Diabetes incidence associated with depression and antidepressants in the melbourne longitudinal studies on healthy ageing (MELSHA). Int J Geriatr Psychiatry. 2009; 26: 341-50.
12. Musselman DL, Betan E, Larsen H, Phillips LS. Relationship of depression to diabetes types 1 and 2: Epidemiology, biology, and treatment. Biol Psychiatry. 2003; 54: 317-29.
13. Eaton WW, Armenian H, Gallo J, Pratt L, Ford DE. Depression and risk for onset of type II diabetes. A prospective population-based study. Diabetes Care. 1996; 19: 1097-102.
14. Everson-Rose SA, Meyer PM, Powell LH et al. Depressive symptoms, insulin resistance, and risk of diabetes in women at midlife. Diabetes Care. 2004; 27: 2856-62.
15. CMS.gov. Centers for Medicare & Medicaid Services. Medicare Current Beneficiary Survey (MCBS). 2012. Available from: http://www.cms.hhs.gov/MCBS/ (accessed 14 February 2012).
16. CMS.gov. Centers for Medicare & Medicaid Services. Limited Data Sets (LDS) Files. 2012. Available from: http://www.cms.hhs.gov/LimitedDataSets/11_MCBS.asp#TopOfPage (accessed 14 February 2012).
17. Buck C. 2010 ICD-9-CM for Physicians, Volumes 1 and 2, Professional Edition. Saunders Elsevier, Maryland Heights, 2009.
18. American Society of Health-System Pharmacists (AHFS). AHFS Drug Information 2009, Micromedex Online, Facts and Comparisons Online. 2011. Available from: http://www.ahfsdruginformation.com/ (accessed 1 December 2011).
19. Sambamoorthi U, Bean-Mayberry B, Findley PA, Yano EM, Banerjea R. Organization of care and diagnosed depression among women veterans. Am J Manag Care. 2010; 16: 657-65.
20. Centers for Disease Control and Prevention. BMI Classification. 2011. Available from: http://www.cdc.gov/healthyweight/assessing/bmi/adult_bmi/index.html (accessed 12 November 2010).
21. Zhang J, Yu KF. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes JAMA. 1998; 280: 1690-1.
22. SAS Institute Inc. SAS 9.2. SAS Institute, Cary. 2009.
23. Chen H, Reeves JH, Fincham JE, Kennedy WK, Dorfman JH, Martin BC. Off-label use of antidepressant, anticonvulsant, and antipsychotic medications among georgia medicaid enrollees in 2001. J Clin Psychiatry. 2006; 67: 972-82.
24. Mezuk B, Eaton WW, Albrecht S, Golden SH. Depression and type 2 diabetes over the lifespan: A meta-analysis. Diabetes Care. 2008; 31: 2383-90.
25. Penninx BW, Leveille S, Ferrucci L, van Eijk JT, Guralnik JM. Exploring the effect of depression on physical disability: Longitudinal evidence from the established populations for epidemiologic studies of the elderly. Am J Public Health. 1999; 89: 1346-52.
26. Poisal JA. Reporting of drug expenditures in the MCBS. Health Care Financ Rev. 2003; 25: 23-36.
27. Strothers HS 3rd, Rust G, Minor P, Fresh E, Druss B, Satcher D. Disparities in antidepressant treatment in Medicaid elderly diagnosed with depression. J Am Geriatr Soc. 2005; 53: 456-61.